PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.690.03 (-4.17%)
0.68 - 0.75
0.33 - 0.86
12.96M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
69.45%
Revenue growth above 1.5x 0819.HK's 36.47%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
283.79%
Gross profit growth above 1.5x 0819.HK's 59.53%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
229.63%
EBIT growth above 1.5x 0819.HK's 91.46%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
229.63%
Operating income growth above 1.5x 0819.HK's 91.46%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
183.19%
Net income growth above 1.5x 0819.HK's 96.01%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
171.60%
EPS growth above 1.5x 0819.HK's 94.52%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
171.60%
Diluted EPS growth above 1.5x 0819.HK's 94.52%. David Dodd would see if there's a robust moat protecting these shareholder gains.
16.23%
Share count expansion well above 0819.HK's 0.64%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
16.16%
Diluted share count expanding well above 0819.HK's 0.86%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-5.02%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.95%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-25.20%
Negative 10Y revenue/share CAGR while 0819.HK stands at 2066.35%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-14.92%
Negative 5Y CAGR while 0819.HK stands at 194.87%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
78.46%
3Y revenue/share CAGR at 75-90% of 0819.HK's 99.68%. Bill Ackman would expect new product strategies to close the gap.
-879.87%
Negative 10Y OCF/share CAGR while 0819.HK stands at 455.24%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-38.06%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-2020.15%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
618.94%
Net income/share CAGR at 50-75% of 0819.HK's 915.52%. Martin Whitman might question if the firm’s product or cost base lags behind.
82.63%
Below 50% of 0819.HK's 370.56%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
135.49%
3Y net income/share CAGR 1.25-1.5x 0819.HK's 122.90%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
109.13%
Below 50% of 0819.HK's 326.31%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-16.14%
Negative 5Y equity/share growth while 0819.HK is at 153.11%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
41.33%
3Y equity/share CAGR at 50-75% of 0819.HK's 80.11%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-91.69%
Cut dividends over 10 years while 0819.HK stands at 178.34%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.95%
Our AR growth while 0819.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-33.37%
Inventory is declining while 0819.HK stands at 11.44%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-10.25%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.50%
We have a declining book value while 0819.HK shows 19.61%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-55.61%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.41%
Our R&D shrinks while 0819.HK invests at 38.54%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
71.83%
SG&A growth well above 0819.HK's 37.60%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.